Related Experiment Video
Updated: Aug 9, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
How will lung cancer be treated in the future?
Hans-Stefan Hofmann1, Babett Bartling
1Department of Cardio-Thoracic Surgery, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097 Halle, Germany. stefan.hofmann@medizin.uni-halle.de
Future Oncology (London, England)
|March 25, 2006
Summary
Lung cancer remains a leading cause of cancer deaths. Innovative treatments targeting molecular mechanisms are crucial as current therapies for lung cancer have reached a plateau.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Lung cancer is the primary cause of cancer mortality in industrialized nations.
- Current 5-year survival rates remain low (14%), showing minimal improvement since the 1960s.
- Established treatments like surgery, chemotherapy, and radiotherapy have led to a survival plateau.
Purpose of the Study:
- To review novel therapeutic strategies for lung cancer.
- To summarize key molecular targets in tumorigenesis and metastasis.
- To highlight ongoing clinical trials for new lung cancer agents.
Main Methods:
- Literature review of molecular approaches in lung cancer.
- Analysis of clinical trials for novel therapeutics.
- Focus on molecular targets of tumorigenesis and metastasis.
Main Results:
- Identification of critical molecular targets in lung cancer development.
- Overview of promising novel therapeutic agents.
- Summary of current clinical trial outcomes and potential.
Conclusions:
- Innovative treatment approaches targeting molecular mechanisms are essential for improving lung cancer survival.
- Further research into molecular targets and novel agents is needed.
- Clinical trials are vital for advancing lung cancer therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.